Delivery Order SPE2DB22D3102-SPE2DB25FL3CS
- Not listed
- The Defense Logistics Agency awarded a $6,752.85 delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5mL syringes. This competitively awarded, firm fixed price contract has a completion date of September 4, 2025, and represents a child order under AmerisourceBergen's broader pharmaceutical supply framework with DLA. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $19,308.06 for PREVNAR 20 vaccine syringes (0.5mL) on August 19, 2025, with an ultimate completion date of August 20, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a pediatric pneumococcal vaccine procurement supporting federal medical supply requirements....
- The Defense Logistics Agency awarded a delivery order valued at $9,458.03 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5 mL) on August 6, 2025, with completion expected by August 7, 2025. This firm fixed-price contract, which is not set-aside, represents a pediatric pneumococcal vaccine procurement supporting federal medical supply requirements. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- The Defense Logistics Agency awarded a delivery order valued at $3,994.00 to AmerisourceBergen Drug Corp for PREVNAR 20 Syringe 0.5ML, a pneumococcal vaccine product. The award, issued on June 16, 2025, with an ultimate completion date of June 17, 2025, was competitively awarded without set-aside restrictions under a firm fixed-price contract type. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania served as the place of performance for this delivery order. This delivery order is...
- The Defense Logistics Agency awarded a $5,859.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5ML syringes. The contract, awarded June 2, 2025, with completion by June 3, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. This delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken,...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $6,535.12 for PREVNAR 20 Syringe 0.5ML on July 11, 2025, with completion scheduled for July 14, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single-line pharmaceutical procurement under the company's broader relationship...
- The Defense Logistics Agency awarded a delivery order valued at $6,926.00 to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in 0.5ml syringes. Issued on July 29, 2025, with an ultimate completion date of July 30, 2025, this firm fixed-price delivery order represents a competitively awarded procurement with no set-aside designation. The vaccine will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine in syringe form (0.5 mL), valued at $1,633.77 with a firm fixed price structure. The contract represents a non-competitive delivery order issued on April 30, 2025, with an ultimate completion date of May 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was issued without set-aside designation, indicating competitive...
- The Defense Logistics Agency awarded a delivery order valued at $8,168.85 to AmerisourceBergen Drug Corp for PREVNAR 20 vaccine syringes (0.5ML) on August 18, 2025, with an ultimate completion date of August 19, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The vaccine will be delivered to AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $4,901.31 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5ML) on August 6, 2025, with an ultimate completion date of August 7, 2025. This competitively awarded, non-set-aside contract represents a small-value transaction for pneumococcal vaccine delivery to support federal medical supply requirements. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL3CSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $5,627.75 to AmerisourceBergen Drug Corp for PREVNAR 20 syringes (0.5ML) on September 18, 2025, with completion scheduled for September 19, 2025. This competitively awarded, firm fixed-price delivery order represents a pediatric pneumococcal vaccine supply to support federal medical procurement needs. The contract carries no set-aside designation, and performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this comprehensive global pharmaceutical support vehicle. The parent IDC encompasses a broad portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 9/18/25 |